electroCore (ECOR) FCF Margin Growth (3y) (2020 - 2026)
electroCore (ECOR) FCF Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 884.00 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 534.00 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 919.00 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 3,472.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -97.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 413.00 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -63.00 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 60.00 |
| 10 | electroCore | 96.39 Mn | 86.35 Mn | 8.18 Mn | -46,138.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -46,138.00 |
| Mar 31, 2026 | 17,938.00 |
| Dec 31, 2025 | 17,411.00 |
| Sep 30, 2025 | 36,635.00 |
| Jun 30, 2025 | 14,222.00 |
| Mar 31, 2025 | 18,567.00 |
| Dec 31, 2024 | 30,905.00 |
| Sep 30, 2024 | 25,317.00 |
| Jun 30, 2024 | 24,331.00 |
| Mar 31, 2024 | 29,819.00 |
| Dec 31, 2023 | -387,872.00 |
| Sep 30, 2023 | 41,565.00 |
| Jun 30, 2023 | 95,809.00 |
| Mar 31, 2023 | 94,628.00 |
| Dec 31, 2022 | 119,301.00 |
| Sep 30, 2022 | 97,280.00 |
| Jun 30, 2022 | 167,247.00 |
| Mar 31, 2022 | 376,133.00 |
| Dec 31, 2021 | 301,720.00 |
| Sep 30, 2021 | 904,987.00 |